Cost-effectiveness of practice-initiated quality improvement for depression: Results of a randomized controlled trial

JAMA

Volumn 286, Issue 11, 2001, Pages 1325-1330

  Schoenbaum, Michael ^a   Unützer, Jürgen ^b   Sherbourne, Cathy ^a   Duan, Naihua ^a,b   Rubenstein, Lisa V ^a,c   Miranda, Jeanne ^b   Meredith, Lisa S ^a   Carney, Maureen F ^a   Wells, Kenneth ^a,b  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; EMPLOYMENT; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPIST; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 0035913572     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.11.1325     Document Type: Article

References (43)

1. Epidemiology of depression in primary care
2. Utility of a new procedure for diagnosing mental disorders in primary care: The Prime-MD 1000 study
3. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
4. Recognition, management, and outcomes of depression in primary care
5. Health care utilization and costs among patients treated for bipolar disorder in an insured population
6. Medical costs attributed to depression among patients with a history of medical expenses in a health maintenance organization
7. Quality adjusted life years in older adults with depressive symptoms and chronic medical disorders
8. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices
9. The quality of care for depressive and anxiety disorders in the United States
10. How can care for depression become more cost-effective?
11. Collaborative management to achieve treatment guidelines: Impact on depression in primary care
12. A multifaceted intervention to improve treatment of depression in primary care
13. Treatment costs, cost offset and cost-effectiveness of collaborarive management of depression
14. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care
15. Effects of a clinical practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire-Depression Project randomized controlled trial
16. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care
17. Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial
18. Evidence-based interventions for depression in managed primary care practices
19. Effectiveness research and implications for study design: Sample size and statistical power
20. Estimation of utilities for the effects of depression from the SF-12
21. Empirically defined health states for depression from the SF-12
22. Cost-effectiveness of treatments for major depression in primary care practice
23. Treating major depression in primary care practice: 8-month clinical outcomes
24. The CES-D Scale: A self-report depression scale for research in the general population
25. Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications
26. The Beaver Dam Health Outcomes Study: Initial catalog of health state quality factors
27. Preliminary longitudinal assessment of quality of life in patient with major depression
28. Depressive symptoms and the cost of health services in HMO patients aged 65 and older: A 4-year prospective study
29. A comparison of alternative models for the demand of medical care
30. Smearing estimate: A nonparametric retransformation method
31. The logged dependent variable, heteroscedasticity, and the retransformation problem
32. Pattern-mixture models for multivariate incomplete data
33. Five-hundred life-saving interventions and their cost effectiveness
34. The value of remaining life is close to estimated values of life